A forum for researchers, students and applicants in the field of cyclodextrin technology
In this study, a whole-cell approach is used for biocatalytic 25OH-VitAMIN D3 synthesis, in which a molybdenum-dependent steroid C25 dehydrogenase was
Inventors, who made a significant contribution to innovation, economy and society in Europe have been awarded since 2006 by the
Oculis the Icelandic (now global) ophthalmology company, founded by Thorsteinn Loftsson and Einar Stefánsson, celebrated its public listing on the
Thorsteinn Loftsson recently published a series of review articles which sums up his advances in ophthalmic drug delivery. This blog
Cyclodextrins are excellent excipients for various routes of administration, the ophthalmic delivery is potentially one of the most useful applications
The yearly exhibition, conference and partnering event of the Biotechnology Innovation Organization (BIO), will be held between June 10-11 and
Oculis, the Icelandic-Swiss clinical stage boipharmaceutical company recently announced that they are progressing towards Phase 3 with OCS-01 in two
Oculis, the Icelandic-Swiss clinical stage boipharmaceutical company recently reported new clinical data at the Americal Society of Cataract and Refractive
Cyclo Therapeutics reported the publication of an international patent application for the treatment of Alzheimer’s disease with HPBCD.
Cyclodextrins have not been popular excipients for nasal or pulmonary drug delivery so far. This can change soon, with the
